Innospec (NASDAQ:IOSP - Get Free Report) issued its quarterly earnings data on Tuesday. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.05, Zacks reports. The firm had revenue of $466.80 million during the quarter, compared to the consensus estimate of $447.43 million. Innospec had a net margin of 1.93% and a return on equity of 12.27%.
Innospec Price Performance
NASDAQ:IOSP traded up $0.31 during mid-day trading on Friday, reaching $103.46. The stock had a trading volume of 281,005 shares, compared to its average volume of 130,141. The stock has a 50-day simple moving average of $110.87 and a two-hundred day simple moving average of $112.43. The stock has a market capitalization of $2.58 billion, a PE ratio of 72.86 and a beta of 1.09. Innospec has a 12 month low of $99.49 and a 12 month high of $133.71.
Analysts Set New Price Targets
Separately, StockNews.com downgraded shares of Innospec from a "strong-buy" rating to a "buy" rating in a research report on Saturday, January 11th.
Get Our Latest Stock Analysis on Innospec
Innospec Company Profile
(
Get Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Featured Stories

Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.